阿斯利康 2024年年度报告 Full Year and Q4 2024 Results Conference call and webcast for investors and analysts.docx

下载文档

0
0
约4.85万字
约 92页
2025-02-11 发布于山西
举报
版权申诉
保障服务

阿斯利康 2024年年度报告 Full Year and Q4 2024 Results Conference call and webcast for investors and analysts.docx

1、本文档共92页，可阅读全部内容。
2、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

FullYearand

Q42024Results

Conferencecallandwebcastforinvestorsandanalysts

06February2025

Forward-lookingstatements

Thisdocumentcontainscertainforward-lookingstatementswithrespecttotheoperations,performanceandfinancialconditionoftheGroup,

including,amongotherthings,statementsaboutexpectedrevenues,margins,earningspershareorotherfinancialorothermeasures.Althoughthe

Groupbelievesitsexpectationsarebasedonreasonableassumptions,anyforward-lookingstatements,bytheirverynature,involverisksand

uncertaintiesandmaybeinfluencedbyfactorsthatcouldcauseactualoutcomesandresultstobemateriallydifferentfromthosepredicted.Theforward-lookingstatementsreflectknowledgeandinformationavailableatthedateofpreparationofthisdocumentandtheGroupundertakesno

obligationtoupdatetheseforward-lookingstatements.TheGroupidentifiestheforward-lookingstatementsbyusingthewords‘anticipates’,‘believes’,

‘expects’,‘intends’andsimilarexpressionsinsuchstatements.Importantfactorsthatcouldcauseactualresultstodiffermateriallyfromthose

containedinforward-lookingstatements,certainofwhicharebeyondtheGroup’scontrol,include,amongotherthings:theriskoffailureordelayin

deliveryofpipelineorlaunchofnewmedicines;theriskoffailuretomeetregulatoryorethicalrequirementsformedicinedevelopmentorapproval;

theriskoffailuresordelaysinthequalityorexecutionoftheGroup’scommercialstrategies;theriskofpricing,affordability,accessandcompetitive

pressures;theriskoffailuretomaintainsupplyofcompliant,qualitymedicines;theriskofillegaltradeintheGroup’smedicines;theimpactofrelianceonthird-partygoodsandservices;theriskoffailureininformationtechnologyorcybersecurity;theriskoffailureofcriticalprocesses;theriskoffailuretocollectandmanagedataandAIinlinewithlegalandregulatoryrequir